The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Delayed Care: Research Paints Complex Picture of Treatment Delays

Delayed Care: Research Paints Complex Picture of Treatment Delays

September 11, 2018 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Delivering messages correctly can be tricky, because they can cause unnecessary alarm, she said. “We need to be very careful about the types of messages which we deliver,” she said. “They must be carefully framed so they don’t increase anxiety among people who have hypochondriasis—general health anxiety—and increase the number of people going to see healthcare professionals with symptoms that don’t need medical intervention. So they do have to be carefully crafted.”

You Might Also Like
  • Complex Treatment: Cancer, Immunotherapy & Rheumatic Disease
  • Long Delays for Appointments Underscore Need for More Rheumatologists
  • Gout Treatment & Care Remain Suboptimal
Explore This Issue
September 2018
Also By This Author
  • Turbocharge Your Cell Analysis with Mass Cytometry

Why Patients Delay Care
Kristien Van der Elst, a PhD student and registered nurse at KU Leuven in Belgium, said research at her center has found psycho social factors, such as a belief that an outcome is inevitable regardless of whether a patient seeks help, play nearly as big a role in determining how long patients delay seeking treatment as the clinical factors themselves, such as swollen joint counts.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In an exploratory study of the CareRA trial, designed to determine optimal care for patients with early RA, 112 patients completed questionnaires on such things as how they perceive their disease and their coping strategies.2

Factors linked to longer delay included a strong belief in an inevitable or innocent disease cause; passive reacting, or the feeling of being totally overwhelmed by a problem situation; a limited understanding of the condition; a low number of swollen joints; and poor expectations the treatment will be able to control the disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In their analysis, psychosocial factors, such as illness perceptions and coping strategies, accounted for about 18% of the variability of patient delay, while clinical factors accounted for about 15%, Ms. Van der Elst said. Two-thirds of the variability in delay could not be explained by any of the factors they examined, she said.

Two patients seen at her center illustrate how psychosocial factors can play a pivotal role in delay. One woman was a general practitioner and contacted the rheumatology department after noticing her hand joints had begun to swell. When erosions on her feet were found, the woman said her feet had been painful and swollen for six months but she thought it was because of new tennis shoes.

“The causal attributions that Sophie related to her first symptoms caused the delay of at least six months in seeking help,” Ms. Van der Elst said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In the other example, a construction worker first saw RA symptoms in his feet eight years before, then finally contacted a doctor because he was losing weight. Over the years, his arthritis had caused severe joint destruction. The error here was that he “thought he could cope” with his joint problems and “seriously misinterpreted the consequences of the symptoms.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: delayed care, EULAR, Europe, patient, Rheumatoid Arthritis (RA)Issue: September 2018

You Might Also Like:
  • Complex Treatment: Cancer, Immunotherapy & Rheumatic Disease
  • Long Delays for Appointments Underscore Need for More Rheumatologists
  • Gout Treatment & Care Remain Suboptimal
  • Self-Monitoring of RA Treatment May Lead to Fewer Office Visits

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)